Akanda Corp Net Assets
Akanda Corp net assets. Based on the latest financial reports, Akanda Corp (AKAN) has net assets worth $-11.99 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.20 Million) and total liabilities ($18.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of Akanda Corp to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-11.99 Million |
| % of Total Assets | -193.53% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 133.07 |
Net Assets of Akanda Corp (2020–2025)
Net assets of Akanda Corp from 2020 to 2025. This chart illustrates how Akanda Corp's net assets have evolved over time, based on quarterly financial data. See AKAN net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for Akanda Corp (2020–2025)
The table below shows the annual net assets of Akanda Corp from 2020 to 2025. For live market cap and overall valuation, see Akanda Corp market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-11.99 Million | -380.38% |
| 2024-12-31 | $4.28 Million | +211.69% |
| 2023-12-31 | $-3.83 Million | -114.23% |
| 2022-12-31 | $26.90 Million | +1321.94% |
| 2021-12-31 | $-2.20 Million | +56.25% |
| 2020-12-31 | $-5.03 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Akanda Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9792926100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Akanda Corp Net Assets Breakdown (December 2025)
Akanda Corp net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $94.61 Million | % |
| Other Comprehensive Income | $-2.30 Million | % |
| Total Equity | $-10.79 Million | 100.00% |
Akanda Corp Competitors by Market Cap
The table below lists competitors of Akanda Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Smart Agro LP
TA:SMAG
|
$562.67K |
|
Foncière 7 investissement Société Anonyme
PA:LEBL
|
$563.20K |
|
Goldflare Exploration Inc
V:GOFL
|
$564.64K |
|
Premier Miton Group plc
LSE:PMI
|
$565.61K |
|
Corcel PLC
LSE:CRCL
|
$562.17K |
|
Leslies Inc
NASDAQ:LESL
|
$561.93K |
|
Taylor Maritime Investments Limited
LSE:TMIP
|
$561.73K |
|
Splash Beverage Group Inc
NYSE MKT:SBEV
|
$561.46K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Akanda Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,276,538 to -10,785,074, a change of -15,061,612 (-352.2%).
- Net loss of 45,653,948 reduced equity.
- New share issuances of 275,929 increased equity.
- Other comprehensive income decreased equity by 717,496.
- Other factors increased equity by 31,033,903.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-45.65 Million | -423.31% |
| Share Issuances | $275.93K | +2.56% |
| Other Comprehensive Income | $-717.50K | -6.65% |
| Other Changes | $31.03 Million | +287.75% |
| Total Change | $- | -352.19% |
Book Value vs Market Value Analysis
This analysis compares Akanda Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-8705.78 | $1.04 | x |
| 2021-12-31 | $-3808.69 | $1.04 | x |
| 2022-12-31 | $38816.97 | $1.04 | x |
| 2023-12-31 | $-348081.09 | $1.04 | x |
| 2024-12-31 | $256.51 | $1.04 | x |
| 2025-12-31 | $-156.44 | $1.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Akanda Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -17690.19%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-23.19%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -111569.88% | 0.00x | 0.00x | $-1.80 Million |
| 2021 | 0.00% | -19625.88% | 0.01x | 0.00x | $-7.91 Million |
| 2022 | -43.34% | -445.00% | 0.07x | 1.45x | $-14.35 Million |
| 2023 | 0.00% | -1494.18% | 0.24x | 0.00x | $-31.89 Million |
| 2024 | -95.78% | -489.57% | 0.11x | 1.85x | $-4.52 Million |
| 2025 | 0.00% | -17690.19% | 0.04x | 0.00x | $-44.58 Million |
Industry Comparison
This section compares Akanda Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $256,218,458
- Average return on equity (ROE) among peers: -51.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Akanda Corp (AKAN) | $-11.99 Million | 0.00% | N/A | $562.47K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $236.15 Million |
| ADC Therapeutics SA (ADCT) | $126.24 Million | -97.51% | 0.19x | $143.73 Million |
| Akebia Ther (AKBA) | $30.76 Million | -42.81% | 0.13x | $189.77 Million |
| Alkermes Plc (ALKS) | $161.37 Million | -10.45% | 1.50x | $7.53 Billion |
| Amylyx Pharmaceuticals Inc (AMLX) | $433.43 Million | 11.37% | 0.19x | $3.12 Billion |
| Amphastar P (AMPH) | $732.30 Million | 21.78% | 1.15x | $980.07 Million |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $61.30 Million | -137.01% | 55.65x | $5.92 Billion |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $208.93 Million | -62.22% | 17.18x | $3.57 Billion |
| Anika Therapeutics Inc (ANIK) | $29.90 Million | 14.38% | 0.08x | $259.76 Million |
About Akanda Corp
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.